Patent · US Active

Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection

US11529381B2 · kind B2 · utility

0Cited by

2References

9Claims

0Family size

Assignee

PrecisionBiotics Group Limited · IE

Inventors

Barry Kiely · Cork, IE
Liam O'Mahony · Cork, IE
David GROEGER · Cork, IE

Key dates

Filing date	Feb 28, 2018
Grant date	Dec 20, 2022
Priority date	—
Expiry date	Feb 28, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12R2001/01
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An isolated strain of Bifidobacterium longum NCIMB 42020 is useful for the treatment of viral infections, especially viral respiratory infections such as influenza, rhinovirus and RSV. Bifidobacterium longum NCIMB 42020 is also useful for clearing secondary bacterial infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.